Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Multiple Sclerosis"" wg kryterium: Temat


Tytuł :
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis.
Autorzy :
Melis M; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Littera R; Complex Structure of Medical Genetics, R. Binaghi Hospital, ASSL Cagliari, ATS Sardegna, Italy.
Cocco E; Multiple Sclerosis Center, R. Binaghi Hospital, University of Cagliari/ATS Sardegna, Cagliari, Italy.
Frau J; Multiple Sclerosis Center, R. Binaghi Hospital, University of Cagliari/ATS Sardegna, Cagliari, Italy.
Lai S; Complex Structure of Medical Genetics, R. Binaghi Hospital, ASSL Cagliari, ATS Sardegna, Italy.
Congeddu E; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Ragatzu P; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Serra M; Complex Structure of Medical Genetics, R. Binaghi Hospital, ASSL Cagliari, ATS Sardegna, Italy.
Loi V; Complex Structure of Medical Genetics, R. Binaghi Hospital, ASSL Cagliari, ATS Sardegna, Italy.
Maddi R; Complex Structure of Medical Genetics, R. Binaghi Hospital, ASSL Cagliari, ATS Sardegna, Italy.
Pitzalis R; Multiple Sclerosis Center, R. Binaghi Hospital, University of Cagliari/ATS Sardegna, Cagliari, Italy.
Orrù S; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Chessa L; Center for the Study of Liver Diseases, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Perra A; Unit of Oncology and Molecular Pathology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Carcassi C; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2019 Dec 17; Vol. 14 (12), pp. e0226615. Date of Electronic Publication: 2019 Dec 17 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS ONE Subsets: MEDLINE
MeSH Terms :
Entropy*
Models, Theoretical*
Immune System Diseases/*etiology
Multiple Sclerosis/*diagnosis
Adult ; Aged ; Case-Control Studies ; Female ; HLA Antigens/chemistry ; HLA Antigens/genetics ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/etiology ; Multiple Sclerosis, Chronic Progressive/diagnosis ; Multiple Sclerosis, Chronic Progressive/etiology ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/etiology ; Pilot Projects ; Receptors, KIR/chemistry ; Receptors, KIR/genetics ; Risk Assessment
Czasopismo naukowe
Tytuł :
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients.
Autorzy :
Ferraro D; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.; Department of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, Modena, Italy.
Guicciardi C; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.
De Biasi S; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Pinti M; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Bedin R; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.
Camera V; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.
Vitetta F; Department of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, Modena, Italy.
Nasi M; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Meletti S; Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.; Department of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, Modena, Italy.
Sola P; Department of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, Modena, Italy.
Pokaż więcej
Źródło :
Acta neurologica Scandinavica [Acta Neurol Scand] 2020 Jan; Vol. 141 (1), pp. 16-21. Date of Electronic Publication: 2019 Aug 26.
Typ publikacji :
Editorial
Journal Info :
Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 0370336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0404 (Electronic) Linking ISSN: 00016314 NLM ISO Abbreviation: Acta Neurol. Scand. Subsets: MEDLINE
MeSH Terms :
Biomarkers/*cerebrospinal fluid
Multiple Sclerosis, Chronic Progressive/*cerebrospinal fluid
Neurofilament Proteins/*cerebrospinal fluid
Adult ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid
Opinia redakcyjna
Tytuł :
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
Autorzy :
Buck D; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany/German Competence Network Multiple Sclerosis (KKNMS), München, Germany.
Andlauer TF; German Competence Network Multiple Sclerosis (KKNMS), München, Germany/Max Planck Institute of Psychiatry, Munich, Germany/Munich Cluster for Systems Neurology (SyNergy), Munich, Germany/Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany.
Igl W; Bayer AG, Berlin, Germany.
Wicklein EM; Bayer AG, Berlin, Germany.
Mühlau M; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany/German Competence Network Multiple Sclerosis (KKNMS), München, Germany.
Weber F; German Competence Network Multiple Sclerosis (KKNMS), München, Germany/Max Planck Institute of Psychiatry, Munich, Germany/Neurological Clinic, Medical Park Bad Camberg, Bad Camberg, Germany.
Köchert K; Bayer AG, Berlin, Germany.
Pohl C; Bayer AG, Berlin, Germany/Department of Neurology, University Hospital of Bonn, Bonn, Germany.
Arnason B; Department of Neurology, Surgery Brain Research Institutes, University of Chicago, Chicago, IL, USA.
Comi G; Department of Neurology and Institute of Experimental Neurology, Università Vita-Salute San Raffaele, Milan, Italy.
Cook S; Rutgers, The State University of New Jersey, Newark, NJ, USA.
Filippi M; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy.
Hartung HP; Department of Neurology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Jeffery D; Piedmont Healthcare, Mooresville, NC, USA.
Kappos L; University Hospital Basel, Basel, Switzerland.
Barkhof F; Radiology and Nuclear Medicine, VU University Medical Centre Amsterdam, The Netherlands/UCL Institutes of Neurology and Healthcare Engineering, London, UK.
Edan G; University of Rennes, Rennes, France.
Freedman MS; University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Montalbán X; Department of Clinical Neuroimmunology, Hospital Vall d'Hebron, Barcelona, Spain.
Müller-Myhsok B; German Competence Network Multiple Sclerosis (KKNMS), München, Germany/Max Planck Institute of Psychiatry, Munich, Germany/Munich Cluster for Systems Neurology (SyNergy), Munich, Germany/Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Hemmer B; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, Germany/German Competence Network Multiple Sclerosis (KKNMS), München, Germany/Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Pokaż więcej
Corporate Authors :
BEYOND and BENEFIT Study Groups
Źródło :
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2019 Apr; Vol. 25 (4), pp. 565-573. Date of Electronic Publication: 2018 Mar 09.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult. Scler. Subsets: MEDLINE
MeSH Terms :
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/genetics
Multiple Sclerosis*/immunology
Antibodies, Neutralizing/*immunology
HLA-DRB1 Chains/*genetics
Immunologic Factors/*immunology
Interferon beta-1b/*immunology
Adult ; Female ; Genome-Wide Association Study ; Humans ; Immunologic Factors/administration & dosage ; Interferon beta-1b/administration & dosage ; Male ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/genetics ; Multiple Sclerosis, Relapsing-Remitting/immunology ; Polymorphism, Single Nucleotide ; Prospective Studies
Czasopismo naukowe
Tytuł :
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Autorzy :
Rocca MA; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy. .
Valsasina P; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Meani A; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Gobbi C; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Zecca C; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Rovira À; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Montalban X; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Kearney H; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Ciccarelli O; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Matthews L; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Palace J; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Gallo A; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Bisecco A; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Gass A; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Eisele P; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Lukas C; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Bellenberg B; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Barkhof F; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Vrenken H; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Preziosa P; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Comi G; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Filippi M; From the Neuroimaging Research Unit (M.A.R., P.V., A.M., P.P., M.F.) and Neurology Unit (M.A.R., P.P., G.C., M.F.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Neurology (C.G., C.Z.), Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano; Faculty of Biomedical Sciences (C.G., C.Z.), Università della Svizzera Italiana, Lugano, Switzerland; Section of Neuroradiology and MRI Unit, Department of Radiology (A.R.), and Department of Neurology/Neuroimmunology (X.M.), Multiple Sclerosis Centre of Catalonia, Hospital Universitari Vall d'Hebron, Barcelona, Spain; NMR Research Unit (H.K., O.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Institute of Neurology, London; Nuffield Department of Clinical Neurosciences (L.M., J.P.), University of Oxford, UK; Department of Advanced Medical and Surgical Sciences, and 3T MRI Center, (A.G., A.B.), University of Campania 'Luigi Vanvitelli,' Naples, Italy; Department of Neurology (A.G., P.E.), Universitätsmedizin Mannheim, University of Heidelberg, Germany; Department of Radiology and Nuclear Medicine (C.L., B.B.) and Institute of Neuroradiology (C.L., B.B.), St. Josef Hospital, Ruhr-University Bochum, Germany; Department of Radiology and Nuclear Medicine (F.B., H.V.), MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, location VUmc, the Netherlands; Institutes of Neurology and Healthcare Engineering (F.B.), University College London, UK; and Vita-Salute San Raffaele University (P.P., G.C., M.F.), Milan, Italy.
Pokaż więcej
Corporate Authors :
MAGNIMS Study Group
Źródło :
Neurology [Neurology] 2019 Nov 12; Vol. 93 (20), pp. e1852-e1866. Date of Electronic Publication: 2019 Oct 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Multiple Sclerosis, Chronic Progressive/*diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting/*diagnostic imaging
Spinal Cord/*diagnostic imaging
Adolescent ; Adult ; Aged ; Atrophy ; Cervical Vertebrae ; Demyelinating Diseases/diagnostic imaging ; Demyelinating Diseases/pathology ; Demyelinating Diseases/physiopathology ; Disease Progression ; Female ; Humans ; Longitudinal Studies ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/diagnostic imaging ; Multiple Sclerosis/pathology ; Multiple Sclerosis/physiopathology ; Multiple Sclerosis, Chronic Progressive/pathology ; Multiple Sclerosis, Chronic Progressive/physiopathology ; Multiple Sclerosis, Relapsing-Remitting/pathology ; Multiple Sclerosis, Relapsing-Remitting/physiopathology ; Spinal Cord/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
Autorzy :
Martin SJ; Anne Rowling Centre for Regenerative Neurology, University of Edinburgh, Edinburgh, UK .; University of Glasgow, Glasgow, UK.
McGlasson S; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Hunt D; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Overell J; University of Glasgow, Glasgow, UK.; Glasgow Multiple Sclerosis Clinical Research Centre, Queen Elizabeth University Hospital, Glasgow, UK.
Pokaż więcej
Źródło :
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2019 Sep; Vol. 90 (9), pp. 1059-1067. Date of Electronic Publication: 2019 May 23.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
Journal Info :
Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-330X (Electronic) Linking ISSN: 00223050 NLM ISO Abbreviation: J. Neurol. Neurosurg. Psychiatry Subsets: MEDLINE
MeSH Terms :
Multiple Sclerosis/*cerebrospinal fluid
Neurofilament Proteins/*cerebrospinal fluid
Case-Control Studies ; Humans ; Multiple Sclerosis/diagnosis ; Multiple Sclerosis, Chronic Progressive/cerebrospinal fluid ; Multiple Sclerosis, Chronic Progressive/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Multiple brain networks support processing speed abilities of patients with multiple sclerosis.
Autorzy :
Manca R; Department of Neuroscience, University of Sheffield , Sheffield , UK.
Mitolo M; IRCCS Istituto delle Scienze Neurologiche di Bologna, Diagnostica Funzionale Neuroradiologica , Bologna , Italy.
Stabile MR; IRCCS Fondazione Ospedale San Camillo , Venice , Italy.
Bevilacqua F; IRCCS Fondazione Ospedale San Camillo , Venice , Italy.
Sharrack B; Academic Department of Neuroscience, Sheffield Teaching Hospital, NHS Foundation Trust , Sheffield , UK.
Venneri A; Department of Neuroscience, University of Sheffield , Sheffield , UK.
Pokaż więcej
Źródło :
Postgraduate medicine [Postgrad Med] 2019 Sep; Vol. 131 (7), pp. 523-532. Date of Electronic Publication: 2019 Sep 16.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Informa Healthcare Country of Publication: England NLM ID: 0401147 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-9260 (Electronic) Linking ISSN: 00325481 NLM ISO Abbreviation: Postgrad Med Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Brain/*diagnostic imaging
Multiple Sclerosis, Chronic Progressive/*diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting/*diagnostic imaging
Adult ; Aged ; Brain/physiopathology ; Cerebellum/diagnostic imaging ; Cerebellum/physiopathology ; Female ; Frontal Lobe/diagnostic imaging ; Frontal Lobe/physiopathology ; Functional Neuroimaging ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/diagnostic imaging ; Multiple Sclerosis/physiopathology ; Multiple Sclerosis/psychology ; Multiple Sclerosis, Chronic Progressive/physiopathology ; Multiple Sclerosis, Chronic Progressive/psychology ; Multiple Sclerosis, Relapsing-Remitting/physiopathology ; Multiple Sclerosis, Relapsing-Remitting/psychology ; Neural Pathways/diagnostic imaging ; Neural Pathways/physiopathology ; Neuropsychological Tests ; Parietal Lobe/diagnostic imaging ; Parietal Lobe/physiopathology ; Psychomotor Performance
Czasopismo naukowe
Tytuł :
Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability.
Autorzy :
Ochoa-Morales A; Department of Genetics, National Institute of Neurology and Neurosurgery MVS, Insurgentes Sur 3877 Col, La Fama, Tlalpan 14269 CDMX, Mexico.
Hernández-Mojica T; Department of Genetics, National Institute of Neurology and Neurosurgery MVS, Insurgentes Sur 3877 Col, La Fama, Tlalpan 14269 CDMX, Mexico.
Paz-Rodríguez F; Department of Neuropsychology, National Institute of Neurology and Neurosurgery MVS, Mexico.
Jara-Prado A; Department of Genetics, National Institute of Neurology and Neurosurgery MVS, Insurgentes Sur 3877 Col, La Fama, Tlalpan 14269 CDMX, Mexico.
Trujillo-De Los Santos Z; Palliative Care Program, National Institute of Neurology and Neurosurgery MVS, Mexico.
Sánchez-Guzmán MA; Violence Research Laboratory, National Institute of Neurology and Neurosurgery MVS, Mexico.
Guerrero-Camacho JL; Department of Genetics, National Institute of Neurology and Neurosurgery MVS, Insurgentes Sur 3877 Col, La Fama, Tlalpan 14269 CDMX, Mexico.
Corona-Vázquez T; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery MVS, Mexico.
Flores J; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery MVS, Mexico; ABC Neurological center, Mexico.
Camacho-Molina A; Department of Genetics, National Institute of Neurology and Neurosurgery MVS, Insurgentes Sur 3877 Col, La Fama, Tlalpan 14269 CDMX, Mexico.
Rivas-Alonso V; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery MVS, Mexico.
Dávila-Ortiz de Montellano DJ; Department of Genetics, National Institute of Neurology and Neurosurgery MVS, Insurgentes Sur 3877 Col, La Fama, Tlalpan 14269 CDMX, Mexico. Electronic address: .
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Nov; Vol. 36, pp. 101386. Date of Electronic Publication: 2019 Sep 09.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
MeSH Terms :
Activities of Daily Living*
Disabled Persons*
Mobility Limitation*
Quality of Life*
Depression/*physiopathology
Multiple Sclerosis/*physiopathology
Adolescent ; Adult ; Aged ; Cross-Sectional Studies ; Depression/etiology ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/complications ; Multiple Sclerosis, Relapsing-Remitting/complications ; Multiple Sclerosis, Relapsing-Remitting/physiopathology ; Young Adult
Czasopismo naukowe
Tytuł :
Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
Autorzy :
Hegedüs K; Department of Neurology, Semmelweis University, Balassa J. u. 6., 1083 Budapest, Hungary. Electronic address: .
Kárpáti J; Department of Neurology, Semmelweis University, Balassa J. u. 6., 1083 Budapest, Hungary.
Iljicsov A; Department of Neurology, Semmelweis University, Balassa J. u. 6., 1083 Budapest, Hungary.
Simó M; Department of Neurology, Semmelweis University, Balassa J. u. 6., 1083 Budapest, Hungary.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Oct; Vol. 35, pp. 150-155. Date of Electronic Publication: 2019 Jul 27.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
MeSH Terms :
Attention/*physiology
Cognition/*physiology
Cognitive Dysfunction/*etiology
Executive Function/*physiology
Memory, Short-Term/*physiology
Multiple Sclerosis/*psychology
Adult ; Affect/physiology ; Cognitive Dysfunction/diagnosis ; Depression/etiology ; Depression/psychology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/complications ; Multiple Sclerosis, Relapsing-Remitting/complications ; Multiple Sclerosis, Relapsing-Remitting/psychology ; Neuropsychological Tests ; Reaction Time/physiology ; Registries ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Clinical outcome measures in multiple sclerosis: A review.
Autorzy :
Inojosa H; MS Center, Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, Fetscherstr. 74, 01307 Dresden, Germany.
Schriefer D; MS Center, Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, Fetscherstr. 74, 01307 Dresden, Germany.
Ziemssen T; MS Center, Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, Fetscherstr. 74, 01307 Dresden, Germany. Electronic address: .
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2020 May; Vol. 19 (5), pp. 102512. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-0183 (Electronic) Linking ISSN: 15689972 NLM ISO Abbreviation: Autoimmun Rev Subsets: MEDLINE
MeSH Terms :
Multiple Sclerosis/*diagnosis
Multiple Sclerosis/*therapy
Disability Evaluation ; Disease Progression ; Humans ; Multiple Sclerosis/physiopathology ; Outcome Assessment, Health Care ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis.
Autorzy :
de Jong CGHM; Department of Biomedical Sciences of Cells & Systems, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Gabius HJ; Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany.
Baron W; Department of Biomedical Sciences of Cells & Systems, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands. .
Pokaż więcej
Źródło :
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2020 Apr; Vol. 77 (7), pp. 1289-1317. Date of Electronic Publication: 2019 Oct 18.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell. Mol. Life Sci. Subsets: MEDLINE
MeSH Terms :
Remyelination*
Galectins/*metabolism
Multiple Sclerosis/*metabolism
Multiple Sclerosis/*therapy
Animals ; Autoantibodies/blood ; Humans ; Models, Biological ; Multiple Sclerosis/blood ; Multiple Sclerosis/pathology ; Myelin Sheath/metabolism
Czasopismo naukowe
Tytuł :
The prevalence and utility of screening for urinary tract infection at the time of presumed multiple sclerosis relapse.
Autorzy :
Fitzgerald KC; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Electronic address: .
Cassard LA; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Fox SR; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Electronic address: .
Probasco JC; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Electronic address: .
Cassard SD; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Electronic address: .
Mowry EM; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Electronic address: .
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Oct; Vol. 35, pp. 61-66. Date of Electronic Publication: 2019 Jul 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
MeSH Terms :
Multiple Sclerosis/*diagnosis
Urinalysis/*standards
Urinary Tract Infections/*diagnosis
Adolescent ; Adult ; Aged ; Comorbidity ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/epidemiology ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/epidemiology ; Predictive Value of Tests ; Prevalence ; Prospective Studies ; Recurrence ; Retrospective Studies ; Risk Factors ; Sex Factors ; Urinary Tract Infections/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis.
Autorzy :
Shi J; School of Science Nantong University, NanTong, P.R. China.
Wu X; Affiliated Hospital of Nantong University, NanTong, P.R. China.
Chen Y; School of Environmental and Chemical Engineering Jiangsu University of Science and Technology, Zhenjiang, P.R. China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2019 Sep 12; Vol. 14 (9), pp. e0222288. Date of Electronic Publication: 2019 Sep 12 (Print Publication: 2019).
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
Journal Info :
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS ONE Subsets: MEDLINE
MeSH Terms :
4-Aminopyridine/*therapeutic use
Multiple Sclerosis/*drug therapy
4-Aminopyridine/pharmacology ; Disabled Persons ; Humans ; Immunosuppressive Agents/therapeutic use ; Mobility Limitation ; Multiple Sclerosis/physiopathology ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/physiopathology ; Range of Motion, Articular
Czasopismo naukowe
Tytuł :
Profile of Polish patients with primary progressive multiple sclerosis.
Autorzy :
Brola W; The Faculty of Medicine and Health Sciences, Institute of Physiotherapy, Jan Kochanowski University, Kielce, Poland. Electronic address: .
Sobolewski P; The Faculty of Medicine and Health Sciences, Institute of Physiotherapy, Jan Kochanowski University, Kielce, Poland. Electronic address: .
Żak M; The Faculty of Medicine and Health Sciences, Institute of Physiotherapy, Jan Kochanowski University, Kielce, Poland. Electronic address: .
Flaga S; AGH University of Science and Technology, Kraków, Poland. Electronic address: .
Fudala M; Department of Neurology, Regional Hospital, Skarżysko-Kamienna, Poland. Electronic address: .
Siutka D; Department of Neurology, Regional Hospital, Skarżysko-Kamienna, Poland. Electronic address: .
Kapica K; Department of Neurology, Medical University of Białystok, Białystok, Poland. Electronic address: .
Chorąży M; Department of Neurology, Medical University of Białystok, Białystok, Poland. Electronic address: .
Kułakowska A; Department of Neurology, Medical University of Białystok, Białystok, Poland. Electronic address: .
Perenc A; Medical Faculty, University of Rzeszów, Rzeszów, Poland. Electronic address: .
Bartosik-Psujek H; Medical Faculty, University of Rzeszów, Rzeszów, Poland. Electronic address: .
Psujek M; Medical Faculty, University of Rzeszów, Rzeszów, Poland. Electronic address: .
Głąbiński A; Department of Neurology and Ischemic Strokes, Medical University of Łódź, Łódź, Poland. Electronic address: .
Pawełczyk M; Department of Neurology and Ischemic Strokes, Medical University of Łódź, Łódź, Poland. Electronic address: .
Gacek S; Department of Neurology, Specialist Hospital, Częstochowa, Poland. Electronic address: .
Potemkowski A; Department of Clinical Psychology and Psychoprophylaxis, University of Szczecin, Poland. Electronic address: .
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Aug; Vol. 33, pp. 33-38. Date of Electronic Publication: 2019 May 21.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
MeSH Terms :
Multiple Sclerosis, Chronic Progressive/*diagnosis
Multiple Sclerosis, Chronic Progressive/*epidemiology
Adult ; Female ; Humans ; Male ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/epidemiology ; Poland/epidemiology
Czasopismo naukowe
Tytuł :
Engaging across dimensions of diversity: A cross-national perspective on mHealth tools for managing relapsing remitting and progressive multiple sclerosis.
Autorzy :
Simblett SK; Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK. Electronic address: .
Evans J; Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Greer B; Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Curtis H; Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Matcham F; Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Radaelli M; Neurology services, San Raffaele Hospital MS centre, Milan, Italy.
Mulero P; Centre d´esclerosi multiple de Catalunya, Hospital Vall d´Hebron, Barcelona, Spain.
Arévalo MJ; Centre d´esclerosi multiple de Catalunya, Hospital Vall d´Hebron, Barcelona, Spain.
Polhemus A; MSD IT Global Innovation Center, Prague, Czech Republic.
Ferrao J; MSD IT Global Innovation Center, Prague, Czech Republic.
Gamble P; MSD IT Global Innovation Center, Prague, Czech Republic.
Comi G; Neurology services, San Raffaele Hospital MS centre, Milan, Italy.
Wykes T; Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
Pokaż więcej
Corporate Authors :
RADAR-CNS consortium
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Jul; Vol. 32, pp. 123-132. Date of Electronic Publication: 2019 Apr 16.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
MeSH Terms :
Cultural Diversity*
Disease Management*
Disease Progression*
Multiple Sclerosis, Relapsing-Remitting/*diagnosis
Multiple Sclerosis, Relapsing-Remitting/*ethnology
Telemedicine/*methods
Adult ; Cross-Sectional Studies ; Female ; Focus Groups ; Humans ; Italy/ethnology ; Male ; Middle Aged ; Multiple Sclerosis/diagnosis ; Multiple Sclerosis/ethnology ; Multiple Sclerosis/psychology ; Multiple Sclerosis, Relapsing-Remitting/psychology ; Spain/ethnology ; United Kingdom/ethnology
Czasopismo naukowe
Tytuł :
Long-term disability progression of pediatric-onset multiple sclerosis.
Autorzy :
McKay KA; From the Department of Clinical Neuroscience (K.A.M., J.H., A.M.), Karolinska Institutet; and Centre for Molecular Medicine (A.M.), Karolinska Hospital, Stockholm, Sweden.
Hillert J; From the Department of Clinical Neuroscience (K.A.M., J.H., A.M.), Karolinska Institutet; and Centre for Molecular Medicine (A.M.), Karolinska Hospital, Stockholm, Sweden.
Manouchehrinia A; From the Department of Clinical Neuroscience (K.A.M., J.H., A.M.), Karolinska Institutet; and Centre for Molecular Medicine (A.M.), Karolinska Hospital, Stockholm, Sweden. .
Pokaż więcej
Źródło :
Neurology [Neurology] 2019 Jun 11; Vol. 92 (24), pp. e2764-e2773. Date of Electronic Publication: 2019 May 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Multiple Sclerosis, Chronic Progressive/*physiopathology
Multiple Sclerosis, Relapsing-Remitting/*physiopathology
Adolescent ; Adult ; Age of Onset ; Aged ; Child ; Child, Preschool ; Cohort Studies ; Delayed Diagnosis ; Disease Progression ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multiple Sclerosis/diagnosis ; Multiple Sclerosis/physiopathology ; Multiple Sclerosis, Chronic Progressive/diagnosis ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Proportional Hazards Models ; Retrospective Studies ; Severity of Illness Index ; Sweden ; Young Adult
Czasopismo naukowe
Tytuł :
Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic.
Autorzy :
Bonavita S; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Piazza Miraglia, 2, 80138, Naples, Italy. .
Tedeschi G; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Piazza Miraglia, 2, 80138, Naples, Italy.
Atreja A; Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Lavorgna L; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Piazza Miraglia, 2, 80138, Naples, Italy.
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2020 May; Vol. 41 (5), pp. 1007-1009. Date of Electronic Publication: 2020 Apr 17.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100959175 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1590-3478 (Electronic) Linking ISSN: 15901874 NLM ISO Abbreviation: Neurol. Sci. Subsets: MEDLINE
MeSH Terms :
Telemedicine*
Coronavirus Infections/*diagnosis
Multiple Sclerosis/*complications
Pneumonia, Viral/*diagnosis
Betacoronavirus ; Coronavirus Infections/epidemiology ; Coronavirus Infections/therapy ; Diagnostic Tests, Routine ; Disease Outbreaks ; Humans ; Immunocompromised Host ; Multiple Sclerosis/therapy ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; Practice Guidelines as Topic ; Triage
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
The COVID-19 pandemic and the use of MS disease-modifying therapies.
Autorzy :
Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London, E1 2AT, UK. Electronic address: .
Hawkes C; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London, E1 2AT, UK.
Lechner-Scott J; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
Levy M; NMO Clinic and Research Laboratory, Division of Neuroimmunology & Neuroinfectious Disease, Massachusetts General Hospital, Boston, USA.
Waubant E; Department of Neurology, UC San Francisco, San Francisco, California, USA.
Gold J; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London, E1 2AT, UK; The Albion Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Apr; Vol. 39, pp. 102073. Date of Electronic Publication: 2020 Mar 27.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
MeSH Terms :
Coronavirus Infections/*epidemiology
Coronavirus Infections/*prevention & control
Multiple Sclerosis/*drug therapy
Pandemics/*prevention & control
Pneumonia, Viral/*epidemiology
Pneumonia, Viral/*prevention & control
Betacoronavirus/isolation & purification ; Coronavirus Infections/immunology ; Humans ; Multiple Sclerosis/epidemiology ; Multiple Sclerosis/immunology ; Multiple Sclerosis/virology ; Pneumonia, Viral/immunology
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Microvascular Decompression for Trigeminal Neuralgia in Patients with Multiple Sclerosis: Predictors of Treatment Success.
Autorzy :
Paulo DL; Department of Neurological Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. Electronic address: .
Lopez AM; School of Medicine, Meharry Medical College, Nashville, Tennessee, USA.
Jermakowicz WJ; Department of Neurological Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Yu H; Department of Neurological Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Shah H; Department of Neurological Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Konrad PE; Department of Neurological Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Englot DJ; Department of Neurological Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Pokaż więcej
Źródło :
World neurosurgery [World Neurosurg] 2020 Apr; Vol. 136, pp. e165-e170. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Country of Publication: United States NLM ID: 101528275 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-8769 (Electronic) Linking ISSN: 18788750 NLM ISO Abbreviation: World Neurosurg Subsets: MEDLINE
MeSH Terms :
Microvascular Decompression Surgery/*methods
Multiple Sclerosis/*complications
Trigeminal Nerve/*diagnostic imaging
Trigeminal Neuralgia/*surgery
Female ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/diagnostic imaging ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome ; Trigeminal Neuralgia/complications ; Trigeminal Neuralgia/diagnostic imaging
Czasopismo naukowe
Tytuł :
Serum Iron and Zinc Levels in Lebanese Multiple Sclerosis Patients.
Autorzy :
Matar A; Department of Biological Sciences, Faculty of Science, Beirut Arab University, Debbieh, Lebanon.
Jennani S; Department of Biological Sciences, Faculty of Science, Beirut Arab University, Debbieh, Lebanon.
Abdallah H; Department of Neurology, Faculty of Medicine, Lebanese University, Beirut, Lebanon.
Mohsen N; Department of Nursing, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.
Borjac J; Department of Biological Sciences, Faculty of Science, Beirut Arab University, Debbieh, Lebanon.
Pokaż więcej
Źródło :
Acta neurologica Taiwanica [Acta Neurol Taiwan] 2020 Mar 30; Vol. 29(1), pp. 5-11.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Color Design Country of Publication: China (Republic : 1949- ) NLM ID: 9815355 Publication Model: Print Cited Medium: Print ISSN: 1028-768X (Print) Linking ISSN: 1028768X NLM ISO Abbreviation: Acta Neurol Taiwan Subsets: MEDLINE
MeSH Terms :
Multiple Sclerosis*
Adult ; Humans ; Iron ; Zinc
Czasopismo naukowe
Tytuł :
Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints.
Autorzy :
Wallis O; Department of Medical Psychology, ETZ Hospital, Tilburg, The Netherlands.
Bol Y; Department of Clinical and Medical Psychology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
Köhler S; School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
van Heugten C; School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands.; Brain Injury Center Limburg, Maastricht, The Netherlands.
Pokaż więcej
Źródło :
Acta neurologica Scandinavica [Acta Neurol Scand] 2020 Mar; Vol. 141 (3), pp. 212-218. Date of Electronic Publication: 2019 Nov 21.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 0370336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0404 (Electronic) Linking ISSN: 00016314 NLM ISO Abbreviation: Acta Neurol. Scand. Subsets: MEDLINE
MeSH Terms :
Anxiety/*psychology
Cognitive Dysfunction/*psychology
Depression/*psychology
Multiple Sclerosis/*psychology
Adult ; Anxiety/etiology ; Cognitive Dysfunction/etiology ; Cross-Sectional Studies ; Depression/etiology ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/complications ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies